| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |